GIT cholestatic liver diseases

100 %
0 %
Information about GIT cholestatic liver diseases

Published on March 3, 2014

Author: shaikhani

Source: slideshare.net

Description

Cholestatic liver diseases

:Cholestatic liver diseases . Dr. Mohammad Shaikhani . MBChB- CABM- FRCP

:Primary Biliary Cirrhosis • PBC occurs primarily in women between 40- 60 years. • The most common symptom is persistent fatigue. • An antimitochondrial antibody titer of ≥1:40 is the serologic hallmark for the diagnosis

:Primary sclerosing Cholangitis • PSC occurs most often in men between 20 - 30 • Up to 80% also have an IBD. • The most common symptoms are pruritus, jaundice, abdominal pain, fatigue. • The diagnosis is confirmed by imaging studies showing a “string of beads” pattern of the intra- & extrahepatic bile ducts. • Patients are at increased risk for developing cholangiocarcinoma , HCC& CRC if with IBD. • Liver transplantation is associated with improved quality of life & survival.

Cholestatic liver disease: DD • • • • • • • Cholestatic phase of viral hepatitis. Drug-induced Herbals-induced cholestasis. Intrahepatic cholestsis of pregnancy. Alcoholic hepatitis. Intrahepatic or extrahepatic biliary obstruction. Metabolic causes as Wilson disease.

Primary Biliary Cirrhosis: EPIDEMIOLOGY • A chronic progressive cholestatic liver disease of unknown cause. • It is an autoimmune disorder occurs predominantly in women (80- 90%) between 40- 60 years. • The prevalence has been increasing, most likely because of earlier diagnosis & increased survival.

Primary Biliary Cirrhosis: Features • The most common symptom is persistent fatigue, occurs in 80%. • Either localized or general pruritus frequently develops. • The pruritus often begins in the perineal area or on the palmar / plantar surfaces typically worse at night or in a warm environment. • Jaundice / abdominal pain may also develop. • Many patients may be asymptomatic at presentation.

Primary Biliary Cirrhosis:Physical exam • Include skin thickening, hyperpigmentation from repeated excoriations, xanthomas, xanthelasma,hepatomegaly. • Patients with advanced disease may have clinical manifestations of portal hypertension. • Other autoimmune diseases are frequently present. • Metabolic bone disease, hypercholesterolemia, fat-soluble vitamin deficiencies are common.

Primary Biliary Cirrhosis: Diagnosis • The diagnostic triad includes cholestatic liver profile, positive antimitochondrial antibody titers&compatible histologic findings on liver biopsy. • SAP & γ-GT are usually elevated *10 or more above normal. • TSB increases as the disease progresses & a helpful prognostic marker. • An antimitochondrial antibody titer of ≥1:40 is the serologic hallmark occurs in 90-95% . • The titer does not appear to correlate with the severity or progression of the clinical disease. • The diagnosis is confirmed by liver biopsy, characteristically shows nonsuppurative cholangitis plus findings ranging from bile duct lesions to cirrhosis.

Primary Biliary Cirrhosis: Treatment • Treatment with ursodeoxycholic acid improves the biochemical profile, reduces pruritus, decreases progression to cirrhosis, and delays the need for liver transplantation. • Therapy is usually continued indefinitely. • Liver transplantation is considered for patients with intractable pruritus or complications from cirrhosis. • Long-term outcomes tend be better than outcomes achieved for other indications for transplantation.

PSC: Epidemiology • A chronic cholestatic liver disease of unknown cause characterized by progressive bile duct destruction& may lead to secondary biliary cirrhosis. • The disease develops more often in men than in women (3:1), generally occurs in patients 20-30 years. • Up to 80% have an IBD (most often ulcerative colitis), but < 5% with UC develop PSC.

PSC: Features • The most common presenting symptoms are pruritus, jaundice, abdominal pain, fatigue, although almost 50% of patients are asymptomatic at initial diagnosis. • Patients with more advanced disease may present with cirrhosis & related complications. • Other associated disorders include bacterial cholangitis, pigmented bile stones, steatorrhea, malabsorption, metabolic bone disease.

PSC: Diagnosis • Lab findings include a cholestatic liver profile, with SAP *3-5> normal& mild hyperbilirubinemia. • The diagnosis is confirmed by ERCP or MRCP that shows findings of multifocal strictures / dilatation of the intra& extrahepatic bile ducts, resembling beads on a string. • Liver biopsy is usually done for staging rather than for diagnosis may show histologic findings ranging from portal hepatitis to biliary cirrhosis. • The classic histologic lesion, termed periductal (“onionskin”) fibrosis, is seen in only 10% of biopsy specimens.

Primary Sclerosing Cholangitis: DD • Bile duct surgical injury. • Infectious cholangitis (including AIDS cholangiopathy) • Malignancy.

PSC: Complications • • • • • • • Cholangiocarcinoma CC ( 10-30%). Detecting CC at an early stage is difficult. Tumor markers CA 19-9+/- CEA Cytologic sampling Advanced imagings with cholangioscopic biopsy. Patients with advanced disease& cirrhosis are at risk for HCC. Patients with both PSC& UC have an increased risk of CRC& aggressive surveillance needed.

PSC: Management • Includes assessment & management of dominant strictures • Treatment of superimposed bacterial cholangitis • Symptomatic therapy. • Only liver transplantation appimprove overall survival & quality of life. • Up to date no TRT has provided the long-term benefits of transplantation. • Median survival from the time of diagnosis is 12 years.

Add a comment

Related presentations

Related pages

Cholestatic Liver Diseases - Product Areas | Aptalis

Cholestatic Liver Diseases: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Cells in the liver produce bile, which passes through ducts ...
Read more

Cholestatic liver diseases | Genfit

Home - Therapeutic areas - Cholestatic liver diseases. ... Primary sclerosing cholangitis is a cholestatic liver disease that affects extra- and ...
Read more

EASL Clinical Practice Guidelines: Management of ...

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases European Association for the Study of the Liver* Keywords: Primary biliary ...
Read more

Primary biliary cirrhosis - Wikipedia, the free encyclopedia

Primary biliary cirrhosis, ... An explanation of cholestatic liver disease of which primary biliary cirrhosis is a type. People with PBC experience fatigue ...
Read more

Cholestasis - Wikipedia, the free encyclopedia

Cholestasis is a condition where bile cannot flow from the liver to the ... Alcoholic liver disease; Liver failure. Hepatic encephalopathy; Acute liver ...
Read more

Cholestatic liver injury due to ibuprofen.

Cholestatic liver injury due to ibuprofen. ... Disease Progression; Humans; Ibuprofen/adverse effects* Liver/pathology; Male; Substances.
Read more

VIEWPOINTS ON DIGESTIVE DISEASES Bone Disease in ...

January 1995 BONE DISEASE IN CHOLESTATIC LIVER DISEASE 277 For stable bone mass, resorption and formation are in equilibrium. Many factors ...
Read more

Cholestatic liver disease. - National Center for ...

Gossard AA(1), Talwalkar JA. Author information: (1)Cholestatic Liver Disease Study Group, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 ...
Read more